Form 4: Alignment Healthcare CEO John Kao Sells 90,000 Shares Under 10b5-1 Plan

Alignment Healthcare's CEO, John Kao, sold 90,000 shares of common stock at an average price of $14.8381 per share under a pre-arranged 10b5-1 trading plan.

Summary

• John Kao, the CEO of Alignment Healthcare, sold 90,000 shares of common stock on May 12, 2025.
• The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 14, 2024.
• The shares were sold at a weighted-average price of $14.8381, with individual sales ranging from $14.70 to $15.15 per share.
• Following the transaction, Mr. Kao directly owns 4,923,186 shares and indirectly owns 1,913,100 shares through the JEK Trust, dated February 8, 2021, of which he is the trustee.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale under a pre-arranged plan. It doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

Executive stock sales are a common occurrence, and sales under 10b5-1 plans are generally viewed as less impactful since they are pre-planned. Investors often monitor insider transactions for signals about a company's prospects.

Stakeholder Impact

• The stock sale could have a minor impact on shareholders if it creates downward pressure on the stock price, although the effect is likely to be limited due to the pre-planned nature of the sale.

Key Dates

Keywords

Alignment Healthcare, ALHC, John Kao, stock sale, Form 4, 10b5-1 plan, executive compensation, insider trading